Literature DB >> 3369720

Halothane hepatitis patients generate an antibody response toward a covalently bound metabolite of halothane.

A K Hubbard1, T P Roth, A J Gandolfi, B R Brown, N R Webster, J F Nunn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3369720     DOI： 10.1097/00000542-198805000-00021

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  5 in total

1.  Human anti-endoplasmic reticulum antibodies in sera of patients with halothane-induced hepatitis are directed against a trifluoroacetylated carboxylesterase.

Authors:  H Satoh; B M Martin; A H Schulick; D D Christ; J G Kenna; L R Pohl
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

Review 2.  The role of gut mucosal hypoperfusion in the pathogenesis of post-operative organ dysfunction.

Authors:  M G Mythen; A R Webb
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

Review 3.  Halothane and hepatitis. Incidence, predisposing factors and exposure guidelines.

Authors:  J M Neuberger
Journal:  Drug Saf       Date:  1990 Jan-Feb       Impact factor: 5.606

Review 4.  Comparative tolerability profiles of the inhaled anaesthetics.

Authors:  J P Fee; G H Thompson
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

5.  Absence of anti-trifluoroacetate antibody after halothane anaesthesia in patients exhibiting no or mild liver damage.

Authors:  Y Sakaguchi; S Inaba; K Irita; H Sakai; H Nawata; S Takahashi
Journal:  Can J Anaesth       Date:  1994-05       Impact factor: 5.063
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.